AH

Ardent Health Partners, LLC

ARDTยทNYSE

$7.83

-16%
HealthcareMedical - Care Facilities

Ardent Health Partners, LLC owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, LLC is a subsidiary of EGI-AM Investments, L.L.C.

At a Glance

Live Snapshot
Market Cap$1.12B
EPS0.9600
P/E Ratio8.16
Earnings Date08/04/2026

Intrinsic Alpha Methodology

Thesis Lenses

Signal ยท Driver ยท Risk

Signal

High confidence

Valuation multiple is compressed (P/E 8.2).

Valuation inputs: P/E 8.2, earnings yield +12.3%, momentum -15.5%.

If multiples stay elevated while momentum fades, downside repricing risk rises.

Driver

High confidence

Return profile is soft (ROE +8.1%, ROIC +6.1%).

Profitability stack: net margin +2.1%, ROE +8.1%, ROIC +6.1%.

Quality deterioration often appears in margins before it shows up in headline EPS.

Risk

High confidence

Downside profile is elevated and scenario stress-testing is essential.

Risk factors: liabilities/assets +68.1%, momentum -15.5%, net margin +2.1%.

Higher leverage with weak momentum and thin margins can amplify drawdown severity.

a

Ardent Health Partners, LLC Market vs Earnings Trajectory

ARDT ยท NYSE

Loading price and EPS data...

AH

Ardent Health Partners, LLC Fair Value Envelope

ARDT ยท NYSE

Our analysis suggests that ARDT has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $7.83, this represents a potential HIDDEN relative to our calculated worth for Ardent Health Partners, LLC.

Intrinsic Value
Current Price: $7.83
3Y-27.0%
5Y-195.0%
10Y-391.0%
3Y+23.0%
5Y+52.0%
10Y+212.0%
3Y-28.0%
5Y-195.0%
10Y-393.0%
3Y-1327.0%
5Y+195.0%
10Y+293.0%
3Y-236.0%
5Y-24246.0%
10Y+558.0%
3Y+9.0%
5Y+123.0%
10Y+387.0%
AH

Ardent Health Partners, LLC Profit Bridge

ARDT ยท NYSE
Revenue6.32B
Cost of Goods Sold (155.70M)
Gross Profit6.17B
Operating Expenses (5.84B)
Operating Income325.58M
Interest Expense (55.20M)
Other Income/Expense-39.23M
Pretax Income286.36M
Income Tax (56.22M)
Net Income135.81M
Net Income
135.81M

Profitability Analysis

Gross Margin

97.5%

Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.

Operating Margin

5.1%

Acceptable margins but limited operational leverage. Operating expense control is important.

Net Profit Margin

2.1%

Minimal profitability after all expenses. Limited financial flexibility for reinvestment or shareholder returns.

Effective Tax Rate

19.6%

Moderate tax rate typical for most corporations. Represents standard tax burden on profits.

Profitability Insight

Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.

97.54%
Gross Profit Margin
18%
3Y+20.0%
5Y-2.0%
10Y-2.0%
5.15%
Operating Profit Margin
-24%
3Y+22.0%
5Y+43.0%
10Y-17.0%
2.15%
Net Profit Margin
-39%
3Y-42.0%
5Y-162.0%
10Y-194.0%
8.05%
Return on Equity
-57%
3Y-73.0%
5Y-119.0%
10Y-
2.57%
Return on Assets
-40%
3Y-34.0%
5Y-149.0%
10Y-
6.13%
Return on Invested Capital
-26%
3Y+36.0%
5Y-3.0%
10Y-
A

Ardent Health Partners, LLC Cash Conversion Engine

ARDT ยท NYSE
Net Income230.13M
Depreciation & Amortization155.70M
Stock-Based Compensation39.29M
Change in Working Capital-3.34M
Others5.13M
Capital Expenditures-211.90M
Free Cash Flow258.61M

Cash Flow Quality Analysis

FCF Conversion Rate

112.4%

Excellent cash generation. The company converts earnings to cash at or above 100%, indicating high-quality earnings.

CapEx Intensity

45.0%

Capital-intensive operations require significant reinvestment. Monitor whether CapEx is maintenance or growth-oriented.

FCF Growth Trend

+102.8%

Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.

Working Capital Impact

-$3.34M

Minimal working capital impact on FCF. Changes in operating assets and liabilities well-managed.

Cash Flow Quality Insight

Exceptional cash generation: High-quality earnings converting to growing free cash flow. The company demonstrates strong pricing power, efficient operations, and disciplined capital allocation.

a

Ardent Health Partners, LLC Funding & Solvency Profile

ARDT ยท NYSE
Cash & Cash Equivalents609.69M
Net Receivables685.99M
Inventory119.84M
Other Current Assets604.63M
Total Current Assets2 B
Property, Plant & Equipment2.14B
Goodwill & Intangible Assets967.60M
Long-Term Investments0.00
Other Non-Current Assets116.27M
Total Non-Current Assets2 B
Total Assets
5.25B

Financial Health Analysis

Current Ratio

2.12x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

2.03x

High financial leverage. Heavy reliance on debt may indicate increased financial risk and potential solvency concerns.

Working Capital

1 B

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

38% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Financial Health Insight

Mixed signals: Strong short-term liquidity provides comfort, but high overall leverage requires careful monitoring of debt servicing capabilities and refinancing risk.

a

Ardent Health Partners, LLC Street Expectations Map

ARDT ยท NYSE

Wall Street analysts project that ARDT stock may rise significantly over the coming 12 months. The consensus 1-year price target stands at 13.00, with estimates ranging from a low of 12.00 to a high of 14.00.

Lowest Target
12.00
53.26%
Consensus Target
13.00
66.03%
Highest Target
14.00
78.80%

The consensus 1-year price target stands at 13.00, with estimates ranging from a low of 12.00 to a high of 14.00.

Analyst Consensus Analysis

Upside Potential

+66.0%

Substantial upside potential. Analysts see significant value gap, suggesting the stock may be materially undervalued at current levels.

Analyst Agreement

15.4% spread

High analyst agreement. Narrow target range indicates strong consensus on valuation, suggesting clear investment thesis and predictable outlook.

Analyst Conviction

Very High

Strong buy conviction: High upside with tight consensus suggests compelling investment opportunity backed by analyst confidence.

Market Sentiment Insight

Rare opportunity: Exceptional upside potential with strong analyst consensus creates a compelling setup. The combination of significant price target premium and tight agreement suggests high-conviction undervaluation that may attract institutional capital.

a

Ardent Health Partners, LLC Insider Positioning

ARDT ยท NYSE

During the last 12 months, insiders have sold $62K worth of ARDT shares, with no buying activity reported.

3 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

3-6 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

6-9 Months

Bought

0

0.00

Sold

4.7K

62.00K

Net Activity

-62K

-$62K

9-12 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

Top Buyers

No buying activity

Top Sellers

1
LA

Lumsdaine Alfred

Officer: Chief Financial Officer

3.4K sharesโ€ข1 transactions

$45K

2
PSC

Petrovich Stephen C.

Officer: Evp, Gc And Asst. Secretary

788 sharesโ€ข1 transactions

$10K

3
BDR

Byers David Raynor

Officer: Svp & Chief Accounting Officer

524 sharesโ€ข1 transactions

$7K

Insider Activity Analysis

Net Insider Sentiment

Bearish

Strong bearish signal with $62K net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.

Buy/Sell Ratio

0.00:1

Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.

Insider Participation

High Selling

3 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.

No Dividend Yield Data

ARDT has not reported any dividend yield values in the available annual periods.

ย 

ardt Dividend History

ARDT
10Y CAGR +0%
Latest $0
Annual $0
Stable dividend payments
Last Period: +0%